Insider Stock Trading History of Henos Michael A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Henos Michael A since year 2005. The trader's CIK number is 1222543. At the time of this reporting, Henos Michael A is the Director of Glycomimetics Inc . (stock ticker symbol GLYC). See this page for all insider trading activities at Glycomimetics Inc .

Note that in the past HENOS MICHAEL A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Henos Michael A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-19 GLYC Glycomimetics Inc Sale 10,598 8.61 91,280
2014-12-22 GLYC Glycomimetics Inc Sale 10,659 8.44 89,908
2014-12-15 GLYC Glycomimetics Inc Sale 1,604 8.98 14,403
2014-12-17 GLYC Glycomimetics Inc Sale 5,121 8.97 45,935
2014-06-12 GLYC Glycomimetics Inc Buy 6,000 6.54 39,240
2014-06-13 GLYC Glycomimetics Inc Buy 5,000 6.21 31,050
2014-04-03 GLYC Glycomimetics Inc Option Ex 1,562 1.12 1,749
2012-01-11 INHX Inhibitex Inc Option Ex 18,000 8.79 158,219
2011-11-02 INHX Inhibitex Inc Option Ex 36,000 3.88 139,680
2010-03-16 GXDX Genoptix Inc Sale 5,000 35.50 177,485
2009-07-01 GXDX Genoptix Inc Sale 7,419 31.91 236,769
2008-12-16 GXDX Genoptix Inc Option Ex 1,181 30.76 36,327
2008-10-31 AGIXQ.PK Atherogenics Inc Sale 100,000 .06 6,300
2008-08-14 GXDX Genoptix Inc Sale 618,646 37.00 22,889,902
2008-03-10 GXDX Genoptix Inc Sale 66,705 25.50 1,700,977
2008-03-05 GXDX Genoptix Inc Sale 397,034 25.50 10,124,367
2007-12-06 AGIX Atherogenics Inc Sale 30,000 .48 14,400
2007-11-02 GXDX Genoptix Inc Sale 236,629 17.00 4,022,693

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henos Michael A (Director of Glycomimetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.